Latest

News & progress

We follow the science closely and share what matters most for our families.

Joint statement on Modalis' MDL-101 program for LAMA2

Cure CMD, Voor Sara, and Modalis shared an update on MDL-101 — a one-time gene therapy for LAMA2 now heading toward its first clinical trial.

Have questions?

Get in touch if you have questions about the clinical trial or the registry.

You can contact us using the form below, by email contact@lama2.bg or on facebook

Your donation supports families and scientific research toward a therapy.

or by bank transfer to our donation account

BG68UBBS80021044245550

Thank you from the heart!